Hamlet BioPharma fortsätter nu serien av livesända digitala investerarmöten, där medarbetare presenterar sitt pågående arbete i bolagets breda projekt-portfölj. Här ges en möjlighet att följa…
Read More
Hamlet BioPharma is pleased to announce a recent article about human breast milk in The Economist, a leading international newspaper. The article highlights the pioneering…
Hamlet BioPharma, the pharmaceutical company, specializing in the development of drugs for cancer and infections, announces that Hamlet BioPharma’s drug candidate Alpha1H has shown potent…
Med anledning bolagets bokslutskommuniké för 2023/2024, bjuder Hamlet BioPharma in till en livesänd digital pressträff onsdagen den 28 augusti klockan 12.00. Bolaget kommer att sammanfatta…
Hamlet BioPharma is pleased to announce the continuation of the digital event series this autumn. These events provide participants a valuable opportunity to follow and…
Alpha1H – Blåscancer: Framgångsrika kliniska studier, Fast-track-status och utveckling av FDA dialog mot Fas III studier. Kliniska data visar starka anti-tumöreffekter hos Alpha1H-behandlade patienter. Dosberoende…
Hamlet BioPharma was selected by Media Planet, the media agency for The Guardian, to be featured in the Health Awareness campaign, BLADDER AND BOWEL HEALTH,…
Hamlet BioPharma, the pharmaceutical company, specializing in the development of drugs for cancer and infections, announce its participation in The Global Forum 2024 By BioStock,…